← SynDRA
BROXATEROL
SynDRA canonical compound SYN0031384 — structure-anchored drug synonym record
| Clinical phase | Phase 3 |
|---|
| Primary target(s) | ADRB2 |
|---|
| Mechanism of action | adrenergic receptor agonist |
|---|
All known targets
Mechanisms of action (all sources)
- adrenergic receptor agonist
- ADRB2 MODULATOR
Drug classes
Cross-references
Synonyms
- Summair
- Z-1170
- Broxaterolum
- ZE4IRB4DUC
- RefChem:121708
- DTXCID90816516
- Broxaterol [INN]
- C9H15BrN2O2
- 1-(3-Bromoisoxazol-5-yl)-2-(tert-butylamino)ethanol
- 1-(3-bromo-1,2-oxazol-5-yl)-2-(tert-butylamino)ethan-1-ol
- MFCD00868978
- Broxaterolum [Latin]
- UNII-ZE4IRB4DUC
- EINECS 278-494-4
- JBRBWHCVRGURBA-UHFFFAOYSA-N
- 1-(3-Brom-5-isoxazolyl)-2-tert-butylaminoethanol
- BROXATEROL [MART.]
- SCHEMBL82745
- orb1703660
- BDBM86449
- EBC-08172
- NSC_71149
- AKOS022666091
- BB166952
- SY213060
- CAS_76596-57-1
- DB-087925
- HY-119985
- CS-0078868
- NS00089521
- EN300-261807
- T23823
- BRD-A08316590-001-01-3
- 1-(3-Bromo-5-isoxazolyl)-2-(tert-butylamino)ethanol #
- Z1269230753
- Isoxazole, 3-bromo-5-[1-hydroxy-2-(t-butylamino)ethyl]-
- بروکساترول
- 溴沙特羅
Look up BROXATEROL in the interactive SynDRA portal →